Vanguard Group Inc Dyne Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,406,344 shares of DYN stock, worth $85.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,406,344

Previous 6,703,926 10.48%

Holding current value

$85.7 Million

Previous $158 Million 50.95%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$10.46 - $25.46 $7.35 Million - $17.9 Million	702,418 Added 10.48%	7,406,344 $77.5 Million
Q4 2024 Feb 11, 2025	SELL	$23.56 - $35.55 $3.77 Million - $5.7 Million	-160,211 Reduced 2.33%	6,703,926 $158 Million
Q3 2024 Nov 13, 2024	BUY	$31.94 - $47.04 $68.5 Million - $101 Million	2,146,083 Added 45.49%	6,864,137 $247 Million
Q2 2024 Aug 13, 2024	BUY	$23.65 - $35.63 $30.2 Million - $45.5 Million	1,277,784 Added 37.14%	4,718,054 $167 Million
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $14.5 Million - $32.4 Million	1,110,629 Added 47.67%	3,440,270 $97.7 Million
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $229,535 - $472,939	-34,673 Reduced 1.47%	2,329,641 $31 Million
Q3 2023 Nov 14, 2023	SELL	$8.6 - $12.18 $210,072 - $297,520	-24,427 Reduced 1.02%	2,364,314 $21.2 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $8.04 Million - $13.5 Million	941,984 Added 65.11%	2,388,741 $26.9 Million
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $2.15 Million - $2.96 Million	-197,653 Reduced 12.02%	1,446,757 $16.7 Million
Q4 2022 Feb 10, 2023	BUY	$9.37 - $13.8 $2.87 Million - $4.22 Million	306,045 Added 22.87%	1,644,410 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $123,408 - $260,013	17,140 Added 1.3%	1,338,365 $17 Million
Q2 2022 Aug 12, 2022	SELL	$4.36 - $10.5 $317,041 - $763,518	-72,716 Reduced 5.22%	1,321,225 $9.08 Million
Q1 2022 May 13, 2022	BUY	$6.52 - $12.27 $7,947 - $14,957	1,219 Added 0.09%	1,393,941 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $1.18 Million - $1.6 Million	99,380 Added 7.68%	1,392,722 $16.6 Million
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $1.22 Million - $1.68 Million	78,459 Added 6.46%	1,293,342 $21 Million
Q2 2021 Aug 13, 2021	BUY	$15.94 - $22.33 $19.4 Million - $27.1 Million	1,214,883 New	1,214,883 $25.6 Million

Others Institutions Holding DYN

# of Institutions

216

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $599M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Dyne Therapeutics, Inc. Transaction History